Anxiety, Stress, & Coping: An International Journal
Anxiety, Stress, & Coping: An International Journal
a b
a b
To cite this article: Denise M. Sloan , Brian A. Feinstein & Brian P. Marx (2009) The durability
of beneficial health effects associated with expressive writing, Anxiety, Stress, & Coping: An
International Journal, 22:5, 509-523, DOI: 10.1080/10615800902785608
To link to this article: http://dx.doi.org/10.1080/10615800902785608
National Center for PTSD, VA Boston Healthcare Systems, 150 S. Huntington Ave, Boston,
MA 02130, USA; bDepartment of Psychiatry, Boston University School of Medicine,
85 E. Newton Street, Boston, MA 02118, USA
Over the past 20 years, a great deal of research has been conducted examining the
beneficial effects associated with expressive writing (also referred to as written
emotional disclosure). The expressive writing procedure typically requires participants to write for at least 20 minutes about a traumatic or stressful event that they
experienced, incorporating both descriptive and emotional information, on 35
consecutive days. The initial beneficial health findings associated with expressive
writing reported by Pennebaker and Beall (1986) have been subsequently replicated
using a variety of populations, with college students representing the sample
most frequently examined (e.g., Greenberg, Wortman, & Stone, 1996; King, 2001;
King & Miner, 2000; Klein & Boals, 2001; Lumley & Provenzano, 2003;
Pennebaker & Francis, 1996; Pennebaker, Kiecolt-Glaser, & Glaser, 1988; Sheese,
Brown, & Granziano, 2004; Sloan & Marx, 2004a; Sloan, Marx, Epstein, &
Lexington, 2007; Ullrich & Lutgendorf, 2002). Although several studies have not
found expressive writing to be associated with health benefits (e.g., Kloss &
Lisman, 2002; see also meta-analysis by Meads & Nouwen, 2005), results from
*Corresponding author. Email: dsloan@bu.edu
ISSN 1061-5806 print/1477-2205 online
This work was authored as part of Contributors official duties as an employee of the United States Government and is
therefore a work of the United States Government. In accordance with 17 U.S.C. 105 no copyright protection is available
for such works under U.S. law.
DOI: 10.1080/10615800902785608
http://www.informaworld.com
510
511
512
18.8 (.6)
20
19.0 (.4)
17
Ethnicity (n)
White
African American
Other
20
10
5
19
9
5
Variable
1034.7 (101.4)
13.2 (3.2)
13.6 (3.6)
1051.8 (110.8)
12.8 (3.1)
13.8 (3.6)
513
Measures
Depression, Anxiety, and Stress Scale 21 item (DASS21; Lovibond & Lovibond,
1995)
The Depression, Anxiety, and Stress Scale (DASS) is a 21-item questionnaire
consisting of items relating to depression, hyperarousal, and stress. A Likert-type
scale is used to rate items according to symptoms experienced in the past week,
ranging from zero (not at all) to three (most of the time). Factor analytic studies with
both clinical and non-clinical samples have shown that the DASS21 items can be
reliably grouped into three scales: depression, anxiety, and stress (Antony, Bieling,
Cox, Enns, & Swinson, 1998) and that the measure differentiates between symptoms
of anxiety and depression, as well as between symptoms of physical arousal and
symptoms of generalized anxiety (e.g., tension; Antony et al., 1998). The depression
subscale is composed of items that measure symptoms associated with depressed
mood (e.g., sadness, worthlessness), and the anxiety subscale includes items that are
related to symptoms of physical arousal, panic attacks, and fear (e.g., trembling,
faintness). Items that measure symptoms, such as tension, irritability, and tendency
to overreact to stressful events comprise the stress subscale. Examples of items from
the depression subscale include, I felt I had nothing to look forward to and I felt
down-hearted and blue. Examples of items from the anxiety subscale include,
I experience trembling and I felt scared without any good reason. Examples of
items from the stress subscale include, I found it hard to relax and I felt that
I was using a lot of nervous energy.
The DASS21 depression subscale has been shown to provide a better separation
of the features of anxiety and depression than other existing measures of depression
and anxiety (Antony et al., 1998; Brown, Chorpita, Korotitsch, & Barlow, 1997;
Lovibond & Lovibond, 1995). Two-week retest reliabilities for the DASS21 subscales
were found to be relatively high at .71, .78, and .81, for the depression, anxiety, and
stress scales, respectively (Antony et al., 1998). In this study, Cronbachs alphas for
the baseline administration of the depression, anxiety, and stress subscales were .94,
.89, and .93, respectively. These internal consistency values are similar to those
reported by Antony and colleagues (1998).
The DASS21 was included in this study because of its strong psychometric
properties and ability to assess several areas of psychological functioning. The
DASS21 has also been used in other expressive writing studies to examine outcome in
psychological functioning (e.g., Epstein et al., 2005).
Pennebaker inventory of limbic languidness (PILL; Pennebaker, 1982)
The Pennebaker inventory of limbic languidness (PILL) is a 54-item self-report
measure that indexes the frequency of a group of common physical symptoms and
sensations. Examples of items from the PILL include, sore throat, congested
nose, upset stomach, heartburn or gas, and chills. Cronbachs alphas range
from .88 to .91 and two-month test-retest reliability ranges from .79 to .83.
Cronbachs alpha in this study was .86 for the baseline administration of the PILL.
Research indicates that high scores on the PILL are significantly associated with
a greater frequency of health center visits and a greater number of days sick and/or
work related absences (Pennebaker, 1982). The PILL is scored by summing the total
514
number of items on which the frequency occurs at least every month. The mean score
on the PILL is 17.9 (SD 4.5) based on a college sample (Pennebaker, 1982). The
PILL was included in this study because we were interested in examining the effect of
expressive writing on physical health outcomes and the PILL is a measure that has
been frequently used in other expressive writing studies (e.g., Epstein et al., 2005;
Sheese et al., 2004; Sloan et al., 2007).
515
they spent their time each day without any emotion or opinions. Participants in both
conditions wrote continuously for 20 minutes each session on three consecutive days.
Participants wrote alone in a private location within the laboratory. After the
participant had read their instructions, they were left alone in the room to write.
After 20 minutes, the experimenter entered the room and instructed the participant
to stop writing. Although participants were given the option of keeping their
narratives, all participants submitted their narratives by placing them back in the
envelope and dropping the envelope into a secured box located within the laboratory.
With the exception of the questionnaires, the same procedure was followed for
the writing sessions completed on the following two days. Participants returned two,
four, and six months later to complete the DASS21 and PILL. Participants were fully
debriefed at the six-month follow-up assessment. Participants who dropped out of
the study prior to the last follow-up assessment were asked to return for a debriefing.
If they did not return for an in-person debriefing, a letter was sent to them that
provided the debriefing information.
Data analysis plan
To investigate the adequacy of randomization, participants assigned to the two
writing conditions were compared on demographic and academic characteristics
using chi-squares (racial background, gender) and t tests (age, SAT total score, credit
hours earned in fall and spring semesters).
An intent-to-treat analysis approach was used to examine outcome. Participants
who did not attend one follow-up assessment session continued to be contacted for
subsequent follow-up assessment sessions. In many cases, we were successful in
participants who had missed one follow-up assessment returning for subsequent
follow-up assessments. In cases in which participants did not return, we used the last
observation carried forward approach. Hence, all 68 participants who completed the
writing sessions were included in the outcome analyses. To examine writing condition
differences on the outcome measures, a 2 (writing condition) 3 (assessment period)
repeated measures of analysis of covariance (ANCOVA) was conducted, with writing
condition as the between subjects variable, assessment period (two month, four
month, and six-month follow-up) as the within subject variable, and baseline score
used as the covariate variable, separately for each self-report outcome measure
(DASS21 depression, DASS21 anxiety, DASS21 stress, PILL). Effect sizes were
calculated using Cohens d (1988).
Results
The analyses examining adequacy of randomization revealed no significant
condition differences in demographic or academic characteristics. Demographic
and academic characteristics as a function of condition are shown in Table 1.
Manipulation check
To examine the effectiveness of writing instructions for the two conditions, ratings of
the extent to which the writing was meaningful, personal, and revealing of emotions
following each of the three writing sessions were averaged. Average ratings were then
516
compared for the writing groups using a t-test. As shown in Table 2, participants
assigned to the expressive writing condition rated their narratives as significantly
more meaningful, personal, and revealing of emotions relative to average ratings of
the participants assigned to the control writing condition. These results indicate that
expressive writing participants complied with the expressive writing instructions and
were engaged in the writing assignment.
In addition to examining participant ratings of their essays, the first and third
authors read each essay to investigate whether the participant complied with the
writing instructions. This review indicated 100% compliance with the writing
instructions.
Outcome assessment
Descriptive information for the outcome measures at baseline and at follow-up
assessments, as a function of condition, is shown in Table 3. An exploratory analysis
of each of the dependent variables was first conducted to examine whether the
assumptions of ANCOVA were met. The exploratory analyses indicated that the
depression, anxiety and stress subscale scores at each assessment period
were significantly skewed. Square root transformations corrected the skew
for each of these variables. The square root transformed variables were used in
our outcome analyses. Exploratory analyses of the PILL and GPA variables
indicated that these variables were normally distributed and therefore no transformations were conducted.
No significant main effects (largest F(2, 65) .72, p.45, d .21) or writing
condition assessment period interaction (F(2, 65) .30, p.70, d.14) were found
for self-reported physical health. The main effects and interaction for the stress
subscale (largest main effect F(2, 65) .21, p.80, d.11; interaction F(2, 65) .21,
p .75, d .11) and anxiety subscale of the DASS21 (largest main effect F(2, 65)
.05, p.90, d.06; interaction F(2, 65) .23, p .75, d.12) were also not
significant. The main effects for writing condition for the depression subscale of
the DASS21 were not significant (largest F(2, 65) 2.54, p .08, d.40), however, a
significant writing conditionassessment period interaction was observed, F(2,
65) 3.60, pB.05, d.47. An ANCOVA, in which baseline depression score was
used as a covariate and Writing condition as the between subject variable, was
conducted for each assessment period to further explore the significant interaction.
As shown in Figure 1, the significant interaction was the result of writing condition
differences at the two-month follow-up assessment (F(2, 65) 3.05, p B.05, d .43).
Table 2. Manipulation check on ratings of the essays.
Expressive writing
condition
Rating
Meaningfula
Personal
Revealing
a
M (SD)
M (SD)
t(66)
3.97 (1.21)
4.25 (.78)
4.08 (.89)
1.28 (.44)
2.56 (1.17)
2.28 (.97)
5.24
7.06
8.00
.001
.001
.001
Rating scale for all three ratings ranged from one (not at all) to five (a great deal).
517
Table 3. Means (and SD) at baseline and follow-up assessments as a function of condition.
Disclosure
Control
2.77 (.71)
2.79 (.65)
2.93 (.74)
3.03 (.64)
DASS21 depression
Baseline
Two months
Four months
Six months
9.50
4.24
8.60
9.35
(8.3)
(9.2)
(9.8)
(8.6)
8.43
8.76
8.20
8.07
DASS21 anxiety
Baseline
Two months
Four months
Six months
3.78
4.00
5.46
6.72
(3.9)
(5.7)
(6.8)
(5.7)
4.38 (5.1)
4.9 (4.8)
6.27 (7.4)
5.70 (7.1)
DASS21 stress
Baseline
Two months
Four months
Six months
9.42
8.18
8.32
8.78
(7.8)
(8.7)
(8.5)
(8.7)
9.62
9.41
8.45
9.62
(7.4)
(8.2)
(7.4)
(9.3)
PILL
Baseline
Two months
Four months
Six months
15.77
15.14
14.77
14.14
(8.3)
(9.9)
(9.7)
(9.8)
16.62
16.19
15.74
16.14
(8.8)
(8.9)
(10.3)
(10.4)
(7.9)
(6.4)
(8.1)
(8.3)
Note: GPA grade point average; DASS21 Depression, Anxiety, and Stress Scale; PILLPennebaker
inventory of limbic languidness.
Outcome measure
16
14
12
*p <.05
10
8
6
4
Disclosure
Control
2
0
Baseline
2 month
4 month
Assessment period
6 month
518
519
possible that the self-reported physical health benefit derived from expressive writing
may have dissipated prior to our first follow-up assessment.
Another possible explanation for our null physical health findings is that our
sample was comprised of healthy young adults. Frattarolis meta-analysis findings
suggest that individuals in poorer physical health reap greater physical health
benefits from expressive writing. If someone is already in good physical health, such
as the sample examined in this study, there is little room for improvement and
therefore it is more difficult to observe beneficial outcome. This ceiling effect
explanation would also apply to the null findings observed for stress and anxiety
outcomes. That is, Frattaroli found that individuals with greater stress levels were
more likely to experience improvements in psychological health. Although our
sample consisted of individuals who were transitioning to college, a period of
elevated stress (Dyson & Renk, 2006), their stress levels may not have been
sufficiently high enough to glean any of the previously noted psychological health
benefits associated with expressive writing, and we did not specifically pre-select
individuals for high levels of stress. In some ways, the fact that we observed a
significant between condition difference for depression symptom severity at the twomonth follow-up assessment is remarkable given that the mean score for depression
symptom severity at baseline was 7.2 for all participants and the range of scores for
both conditions at the two-month follow-up assessment was restricted with the mean
score within normal range (7.9).
Although, some expressive writing studies have found improved GPA to be
associated with expressive writing (Cameron & Nicholls, 1998; Lumley & Provenzano, 2003; Pennebaker & Francis, 1996; Pennebaker et al., 1990), other studies have
found no improvement in GPA (Klein & Boals, 2001; Pennebaker & Beall, 1986).
Moreover, two of the studies that showed improved GPA associated with expressive
writing reported a marginal effect only (Pennebaker & Francis, 1996; Pennebaker
et al., 1990). Frattarolis (2006) meta-analysis revealed a significant but small effect
size for academic outcomes (r.038). Thus, a large sample size may be needed in
order to observe improvements in GPA associated with expressive writing. Although,
the sample size included in our study is consistent with the sample size of other
expressive writing studies (see Frattaroli, 2006), we may not have been sufficiently
powered to find a significant group effect for GPA outcome.
Related to the sample examined in this study, investigators have suggested that
sample characteristics (e.g., college students versus clinical samples) may influence
expressive writing outcome. Smyths (1998) meta-analysis found that expressive
writing studies that used college students had significantly larger psychological
health effect sizes than studies that used non-student populations. In contrast, a
more recent meta-analysis (Frattaroli, 2006) found that studies that used nonstudent populations had marginally larger psychological health effect sizes than
studies that used student populations. Frattaroli (2006) noted that this discrepancy
might be due to another, third variable, location of the writing sessions. That is,
studies that examined student samples were more likely to be conducted in a
controlled setting, such as a laboratory. When location of writing session was used as
a covariate, sample no longer served as a significant moderator of outcome. Taken
together, there is not convincing evidence that the expressive writing procedure is
more or less effective for student versus non-student populations. However, a more
critical issue may relate to individual differences serving as a moderator of expressive
520
writing outcome (e.g., Norman et al., 2004; Sloan, Marx, Epstein, & Dobbs, 2008).
Future studies examining expressive writing outcome should include an examination
of moderators of expressive writing. Although the findings from Frattarolis metaanalysis provide some important information on this topic, it is best to directly
examine moderators of expressive writing outcome so that the influence of
third variables can be controlled. There is also some evidence that altering
the instructional set may lead to greater expressive writing benefits (e.g., Sloan
et al., 2007).
As noted earlier, our study may not have been able to detect between group
differences at follow-up assessments due to low power. Although, Frattaroli (2006)
reported significant effect sizes across a variety of outcome measures, the reffect size for
each outcome category was relatively small (e.g., .056, .054, and .036 for
psychological health, self-reported physical health, and general functioning,
respectively). These relatively small weighted mean effect sizes suggest the need to
include larger sample sizes to detect between group differences in outcome effects. To
investigate whether our study was underpowered to detect between group effects, we
conducted a post hoc power analysis using G*power software (Faul, Erdfelder,
Lang, & Buchner, 2007). Findings indicated that power for the between group
difference of GPA for the fall semester was .26. Thus, we were underpowered to
detect between group effects on GPA. However, post hoc power analyses of our other
outcome variables indicated power was at least .80 (e.g., .86 for the PILL and .92 for
anxiety), which is sufficient to detect between group differences.
Although, there is not clear evidence as to the underlying mechanism for the
health benefits associated with expressive writing, there is growing evidence that the
expressive writing intervention allows individuals the opportunity to express
emotions and feelings surrounding current stressful experiences that they might
not otherwise express (for a review see, Sloan & Marx, 2004b). Therefore, the
intervention should primarily be associated with psychological health benefits.
However, as the mind affects the body (e.g., Irwin, 2008; Kiecolt-Glaser, McGuire,
Robles, & Glaser, 2002; Lutgendorf & Costanzo, 2003), it is reasonable to assume
that other benefits would also be observed. For example, reductions in psychological
stress levels may lead to improvements in physical health (Lovallo, 2005). Thus, if
expressive writing is associated with decreased stress then one would expect to find
decreased physical health problems to follow. Given that we did not find any
improvements in stress levels associated with expressive writing in this study, it is not
surprising that physical health benefits were also not observed. Similarly, if a person
is in good physical and psychological health they will be better able to focus on their
school work as they will not be distracted by physical and psychological health
problems. Consequently, we would expect improvement in academic performance to
follow improvements in psychological and physical health. As we found no benefits
in anxiety, stress or physical health associated with expressive writing, it is not
surprising that we did not observe improvements in academic performance (as
indexed by GPA). In addition, the short-lived reductions in depression symptoms
would not promote longer term additional benefits, such as improved scholastic
performance.
One of the main findings of this study is the short duration of the derived benefits
associated with expressive writing. This finding raises questions regarding whether
expressive writing can be useful as an intervention. On the other hand, it may be
521
necessary to conduct writing sessions on a periodic basis (e.g., every few weeks) in
order to reap the greatest benefit from the expressive writing procedure. As
Pennebaker (1997) has noted, because new stressors occur over time, the expressive
writing intervention might be best implemented by individuals who complete writing
sessions at regular intervals, similar to booster sessions that are commonly used in
psychotherapy (e.g., Baggs & Spence, 1990; Braukhaus, Hahlweg, Kroeger, Groth, &
Fehm-Wolfsdorf, 2003; Clarke, Rohde, Lewinsohn, Hops, & Seeley, 1999; Connors &
Walitzer, 2001), and booster sessions might be particularly useful for relatively
healthy individuals. Gortner, Rude, and Pennebaker (2006) investigated whether a
booster writing session enhanced expressive writing outcome with a college student
sample. No benefit was observed by adding a booster session. It should be noted that
these investigators used only a single booster writing session that occurred five weeks
after the initial expressive writing sessions. Given that follow-up was assessed six
months following the initial writing sessions, the single booster writing session may
have been insufficient to enhance lasting benefits derived from the expressive writing
procedure. Overall, it will be important for investigators to continue to examine
whether booster writing sessions enhance the efficacy of expressive writing.
Taken together, the results of this study add to the large body of research
indicating that expressive writing can be associated with beneficial outcome, at least
in the short term. However, it appears that beneficial outcome may be observed for
some areas of functioning but not others. It is likely that the benefits derived from
the expressive writing task may vary by the sample that is being studied. Durability
of any observed benefit might also vary as a function of domain of assessment. In
order to continue to further our knowledge on how expressive writing is best used, it
will be important for investigators to include multiple assessments over time and to
investigate a variety of health outcomes with different populations. Investigation of
the potential benefit of booster writing sessions should also be pursued.
References
Antony, M.M., Bieling, P.J., Cox, B.J., Enns, M.W., & Swinson, R.P. (1998). Psychometric
properties of the 42-item and 21-item versions of the depression anxiety stress scales in
clinical groups and a community sample. Psychological Assessment, 10, 176181.
Baggs, K., & Spence, S.H. (1990). Effectiveness of booster sessions in the maintenance and
enhancement of treatment gains following assertion training. Journal of Consulting and
Clinical Psychology, 58, 845854.
Batten, S.V., Follette, V.M., Hall, M.L.R., & Palm, K.M. (2002). Physical and psychological
effects of written disclosure among sexual abuse survivors. Behavior Therapy, 33, 107122.
Braukhaus, C., Hahlweg, K., Kroeger, C., Groth, T., & Fehm-Wolfsdorf, G. (2003). The effects
of adding booster sessions to a preventative training program for committed couples.
Behavioural and Cognitive Psychotherapy, 31, 325336.
Broderick, J.E., Junghaenel, D.U., & Schwartz, J.E. (2005). Written emotional expression
produces health benefits in fibromyalgia patients. Psychosomatic Medicine, 67, 326334.
Brown, T.A., Chorpita, B.F., Korotitsch, W., & Barlow, D.H. (1997). Psychometric properties
of the depression anxiety stress scales (DASS) in clinical samples. Behaviour Research and
Therapy, 35, 7989.
Cameron, L.D., & Nicholls, G. (1998). Expression of stressful experiences through writing:
Effects of a self-regulation manipulation for pessimists and optimists. Health Psychology,
17, 8492.
Clarke, G.N., Rohde, P., Lewinsohn, P.M., Hops, H., & Seeley, J.R. (1999). Cognitivebehavioral treatment of adolescent depression: Efficacy of acute group treatment and
522
booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry, 38,
272279.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ:
Earlbaum.
Connors, G.J., & Walitzer, K.S. (2001). Reducing alcohol consumption among heavily
drinking women: Evaluating the contributions of life-skills training and booster sessions.
Journal of Consulting and Clinical Psychology, 69, 447456.
Dyson, R., & Renk, K. (2006). Freshman adaptation to university life: Depressive symptoms,
stress, and coping. Journal of Clinical Psychology, 62, 12311244.
Epstein, E.M., Sloan, D.M., & Marx, B.P. (2005). Getting to the heart of the matter: Written
disclosure, gender, and heart rate. Psychosomatic Medicine, 67, 413419.
Faul, F., Erdfelder, E., Lang, A-G., & Buchner, A. (2007). G*Power 3: A flexible statistical
power analysis program for the social, behavioral, and biomedical sciences. Behavior
Research Methods, 39, 175191.
Frattaroli, J. (2006). Experimental disclosures and its moderators: A meta-analysis.
Psychological Bulletin, 132, 823865.
Frisina, P.G., Borod, J.C., & Lepore, S.J. (2004). A meta-analysis of the effects of written
emotional disclosure on the health outcomes in clinical populations. Journal of Nervous and
Mental Disease, 192, 629634.
Gortner, E.M., Rude, S.S., & Pennebaker, J.W. (2006). Benefits of expressive writing in
lowering rumination and depressive symptoms. Behavior Therapy, 37(3), 292303.
Greenberg, M.A., Wortman, C.B., & Stone, A.A. (1996). Emotional expression and physical
health: Revisiting traumatic memories or fostering self-regulation? Journal of Personality
and Social Psychology, 71, 588602.
Irwin, M.R. (2008). Human psychoneuroimmunology: 20 years of discovery. Brain, Behavior,
and Immunity, 22, 129139.
Kiecolt-Glaser, J.K., McGuire, L., Robles, T.F., & Glaser, R. (2002). Psychoneuroimmunology: Psychological influences on immune function and health. Journal of Consulting and
Clinical Psychology, 70, 537547.
King, L.A. (2001). The health benefits of writing about life goals. Personality and Social
Psychology Bulletin, 27, 798807.
King, L.A., & Miner, K.N. (2000). Writing about perceived benefits of traumatic events:
Implications for physical health. Personality and Social Psychology Bulletin, 26, 220230.
Klein, K., & Boals, A. (2001). Expressive writing can increase working memory capacity.
Journal of Experimental Psychology: General, 130, 520533.
Kloss, J.D., & Lisman, S.A. (2002). An exposure-based examination of the effects of written
emotional disclosure. British Journal of Health Psychology, 7, 3146.
Lepore, S.J. (1997). Expressive writing moderates the relation between intrusive thoughts and
depressive symptoms. Journal of Personality and Social Psychology, 73(5), 10301037.
Lovallo, W.R. (2005). Stress & health. Biological and psychological interactions (2nd ed.).
Thousand Oaks, CA: Sage.
Lovibond, P.F., & Lovibond, S.H. (1995). The structure of negative emotional states:
Comparison of the depression anxiety stress scales (DASS) with the beck depression and
anxiety inventories. Behaviour Research and Therapy, 33, 335342.
Lumley, M.A., & Provenzano, K.M. (2003). Stress management through written emotional
disclosure improves academic performance among college students with physical symptoms.
Journal of Educational Psychology, 95, 641649.
Lutgendorf, S.K., & Costanzo, E.S. (2003). Psychoneuroimmunology and health psychology:
An integrative model. Brain, Behavior, and Immunity, 17, 225232.
Meads, C., & Nouwen, A. (2005). Does emotional disclosure have any effects? A systematic
review of the literature with meta-analyses. International Journal of Technology Assessment
in Health Care, 21, 153164.
Norman, S.A., Lumley, M.A., Dooley, J.A., & Diamond, M.P. (2004). For whom does it work?
Moderators of the effects of written emotional disclosure in a randomized trial among
women with chronic pelvic pain. Psychosomatic Medicine, 66, 174183.
Park, C.L., & Blumberg, C.J. (2002). Disclosing trauma through writing: Testing the meaningmaking hypothesis. Cognitive Therapy and Research, 26, 597616.
523
Pennebaker, J., Kiecolt-Glaser, J., & Glaser, R. (1988). Disclosure of traumas and immune
function: Health implications for psychotherapy. Journal of Consulting and Clinical
Psychology, 56, 239245.
Pennebaker, J.W. (1982). The psychology of physical symptoms. New York: Springer Verlag.
Pennebaker, J.W. (1997). Writing about emotional experiences as a therapeutic process.
Psychological Science, 8, 162166.
Pennebaker, J.W., & Beall, S.K. (1986). Confronting a traumatic event: Toward an understanding of inhibition and disease. Journal of Abnormal Psychology, 95, 274281.
Pennebaker, J.W., Colder, M., & Sharp, L.K. (1990). Accelerating the coping process. Journal
of Personality and Social Psychology, 58, 528537.
Pennebaker, J.W., & Francis, M. (1996). Cognitive, emotional, and language processes in
disclosure. Cognition and Emotion, 10, 601626.
Radcliffe, A.M., Lumley, M.A., Kendall, J., Stevenson, J.K., & Beltran, J. (2007). Written
emotional disclosure: Testing whether social disclosure matters. Journal of Social and
Clinical Psychology, 28, 362384.
Sheese, B.E., Brown, E.L., & Granziano, W.G. (2004). Emotional expression in cyberspace:
Searching for moderators of the Pennebaker disclosure effect via e-mail. Health Psychology,
23, 457464.
Sloan, D.M., & Marx, B.P. (2004a). A closer examination of the structured written disclosure
procedure. Journal of Consulting and Clinical Psychology, 72, 165175.
Sloan, D.M., & Marx, B.P. (2004b). Taking pen to hand: Evaluating possible theories
underlying written disclosure paradigm. Clinical Psychology: Science and Practice, 11,
121137.
Sloan, D.M., Marx, B.P., Epstein, E.M., & Dobbs, J.L. (2008). Expressive writing buffers
against maladaptive rumination. Emotion, 8, 302306.
Sloan, D.M., Marx, B.P., Epstein, E.M., & Lexington, J. (2007). Does altering the
instructional set affect written disclosure outcome? Behavior Therapy, 38, 155168.
Smyth, J.M. (1998). Written emotional expression: Effect sizes, outcome types, and
moderating variables. Journal of Consulting and Clinical Psychology, 66, 174184.
Smyth, J.M., Stone, A., Hurewitz, A., & Kaell, A. (1999). Writing about stressful events
produces symptom reduction in asthmatics and rheumatoid arthritics: A randomized trial.
Journal of American Medical Association, 281, 13041309.
Ullrich, P.M., & Lutgendorf, S.K. (2002). Journaling about stressful events: Effects of
cognitive processing and emotional expression. Annals of Behavioral Medicine, 24, 244250.